These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30723315)
21. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B; J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647 [TBL] [Abstract][Full Text] [Related]
22. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029 [TBL] [Abstract][Full Text] [Related]
23. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Moudgil SS; Riggs JE Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980 [TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132 [TBL] [Abstract][Full Text] [Related]
25. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438 [TBL] [Abstract][Full Text] [Related]
26. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience. Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396 [TBL] [Abstract][Full Text] [Related]
27. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients. Yasu T; Ohno N; Kawamata T; Kurokawa Y Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157 [TBL] [Abstract][Full Text] [Related]
28. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia. Baker SK; Lipson DM J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233 [TBL] [Abstract][Full Text] [Related]
29. Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia. Bacon LC; Barnett MJ; Abou Mourad YR Ann Hematol; 2012 Jun; 91(6):971-2. PubMed ID: 21976108 [No Abstract] [Full Text] [Related]
30. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine. Jain S; Kapoor G Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256 [No Abstract] [Full Text] [Related]
31. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia. Millan NC; Pastrana A; Guitter MR; Zubizarreta PA; Monges MS; Felice MS Leuk Res; 2018 Feb; 65():86-93. PubMed ID: 29328996 [TBL] [Abstract][Full Text] [Related]
32. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment. Gutierrez-Camino Á; Umerez M; Lopez-Lopez E; Santos-Zorrozua B; Martin-Guerrero I; de Andoin NG; Ana S; Navajas A; Astigarraga I; Garcia-Orad A Pharmacogenomics; 2018 Dec; 19(18):1403-1412. PubMed ID: 30479191 [TBL] [Abstract][Full Text] [Related]
33. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Jeng MR; Feusner J Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732 [TBL] [Abstract][Full Text] [Related]
34. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia. Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977 [TBL] [Abstract][Full Text] [Related]
35. Vincristine neurotoxicity in the presence of hereditary neuropathy. Trobaugh-Lotrario AD; Smith AA; Odom LF Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685 [No Abstract] [Full Text] [Related]
36. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study. Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909 [TBL] [Abstract][Full Text] [Related]
37. [Isolated unilateral cranial nerve palsy during childhood acute lymphoblastic leukemia treatment: What does it mean?]. Saumet L; Haouy S; Daien V; Hillaire-Buys D; Roessler J; Sirvent N Arch Pediatr; 2016 Apr; 23(4):415-6. PubMed ID: 26968305 [No Abstract] [Full Text] [Related]